Internal Medicine, Hematology & Oncology · Saint Petersburg, FL
NPI
1861488454
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5000 Park St N Ste 1017
Saint Petersburg, FL, 33709
Phone (727) 344-6569
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
77,092 services
Medicare patients, 2024
270
Average age 74
Drug cost, 2024
$10.2M
2,809 prescriptions
Company payments, 2025
$4,509
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pratibha K Desai was code J1439 (injection, ferric carboxymaltose, 1 mg), 13,500 times for 12 patients. In total Pratibha K Desai billed 77,092 services in 126 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 13,500 | 12 | $0.87 | $12K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 4,879 | 23 | $6.34 | $31K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,602 | 21 | $15.75 | $41K |
| J0897 Injection, denosumab, 1 mg | Office | 1,800 | 13 | $20.40 | $37K |
| 36415 Venipuncture Blood Collection | Office | 885 | 203 | $8.65 | $7,655 |
| 85025 Blood Count | Office | 885 | 198 | $7.61 | $6,735 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 404 | 14 | $0.08 | $32.5 |
| 96372 Injection Administration | Office | 352 | 50 | $10.47 | $3,685 |
| 99213 Office E&M - Established | Office | 309 | 164 | $68.16 | $21K |
| 80053 Clinical Chemistry | Office | 180 | 88 | $10.35 | $1,863 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 156 | 91 | $13.02 | $2,031 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 138 | 20 | $0.70 | $96.01 |
| 82728 Clinical Chemistry | Office | 124 | 65 | $13.36 | $1,657 |
| 99214 Office E&M - Established | Office | 119 | 70 | $93.81 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 108 | 23 | $20.59 | $2,224 |
By year: 2022 $1.1M for 52,524 services; 2023 $868K for 61,671 services; 2024 $1.0M for 77,092 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 885 | 203 | $8.65 | $7,655 |
| 85025 Blood Count | 885 | 198 | $7.61 | $6,735 |
| 80053 Clinical Chemistry | 180 | 88 | $10.35 | $1,863 |
| 82728 Clinical Chemistry | 124 | 65 | $13.36 | $1,657 |
| 83540 Clinical Chemistry | 84 | 45 | $6.34 | $533 |
| 83615 Clinical Chemistry | 35 | 22 | $5.92 | $207 |
| 82378 Clinical Chemistry | 33 | 24 | $18.58 | $613 |
| 82746 Clinical Chemistry | 25 | 25 | $14.41 | $360 |
Medicare prescription drug claims, 2024
In 2024, the drug Pratibha K Desai prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 243 prescriptions and refills. In total Pratibha K Desai wrote 2,809 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 243 | 243 | 75 | $730K |
| Anastrozole Generic | 203 | 482 | 64 | $3,166 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 105 | 109 | 21 | $550 |
| Retacrit Epoetin Alfa-Epbx | 103 | 103 | 40 | $143K |
| Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosp/Pf | 100 | 100 | 25 | $1,300 |
| Letrozole Generic | 96 | 223 | 30 | $1,888 |
| Lenalidomide Generic | 77 | 77 | Under 11 | $952K |
| Diphenhydramine Hcl Generic | 71 | 73 | 17 | $139 |
| Zoledronic Acid Generic | 70 | 81 | 14 | $4,981 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 68 | 68 | Under 11 | $623K |
| Ondansetron Odt Ondansetron | 58 | 64 | 46 | $4,424 |
| Anagrelide Hcl Generic | 53 | 113 | 15 | $16K |
| Jakafi Ruxolitinib Phosphate | 48 | 48 | Under 11 | $773K |
| Prochlorperazine Maleate Generic | 48 | 56 | 40 | $1,706 |
| Calquence Acalabrutinib Maleate | 41 | 41 | Under 11 | $545K |
Brand drugs: 1,233 claims; generic drugs: 1,576 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pratibha K Desai $4,509 ($4,509 in general payments such as food, travel and fees) from 50 companies. The largest payer was Novartis Pharmaceuticals Corporation with $290.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 16 | $290 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $242 |
| Daiichi Sankyo Inc. 4568.T | 8 | $229 |
| Incyte Corporation INCY | 9 | $207 |
| Janssen Biotech, Inc. JNJ | 9 | $207 |
| Lilly USA, LLC LLY | 6 | $204 |
| Abbvie Inc. ABBV | 5 | $199 |
| Pfizer Inc. PFE | 8 | $193 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $189 |
| Cardinal Health 110 LLC | 1 | $176 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.